Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
3.300
-0.020 (-0.60%)
At close: Apr 28, 2026, 4:00 PM EDT
3.530
+0.230 (6.97%)
After-hours: Apr 28, 2026, 6:32 PM EDT
Biodexa Pharmaceuticals Cash Flow Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -6.38 | -5.73 | -7.08 | -7.66 | -5.46 | |
| Depreciation & Amortization | 0.19 | 0.25 | 0.28 | 0.34 | 0.4 | |
| Other Amortization | 0 | 0 | 0 | 0 | - | |
| Loss (Gain) From Sale of Assets | 0.03 | 0 | 0 | 0.01 | -0.04 | |
| Stock-Based Compensation | 0.17 | 0.28 | 0.03 | 0.12 | 0.09 | |
| Other Operating Activities | -1.68 | -3.34 | -0.09 | -0.6 | -0.38 | |
| Change in Accounts Receivable | 2.63 | -5.98 | 0.37 | 0.01 | -0.49 | |
| Change in Accounts Payable | -0.91 | 2.24 | -0.21 | 0.36 | -0.13 | |
| Change in Other Net Operating Assets | - | - | -0.21 | 0.16 | - | |
| Operating Cash Flow | -5.59 | -12.26 | -6.83 | -7.05 | -6.01 | |
| Capital Expenditures | -0 | -0.01 | -0.03 | -0.06 | -0.32 | |
| Sale of Property, Plant & Equipment | 0.02 | - | 0 | 0.02 | 0.04 | |
| Sale (Purchase) of Intangibles | -0.69 | -0.77 | -0.24 | - | - | |
| Other Investing Activities | 0.09 | 0.18 | 0.07 | 0.03 | - | |
| Investing Cash Flow | -0.58 | -0.6 | -0.27 | -0.22 | -0.28 | |
| Short-Term Debt Issued | - | 0.43 | - | - | - | |
| Total Debt Issued | - | 0.43 | - | - | - | |
| Short-Term Debt Repaid | -0.45 | - | - | - | - | |
| Long-Term Debt Repaid | -0.25 | -0.19 | -0.19 | -0.18 | -0.22 | |
| Total Debt Repaid | -0.7 | -0.19 | -0.19 | -0.18 | -0.22 | |
| Net Debt Issued (Repaid) | -0.7 | 0.25 | -0.19 | -0.18 | -0.22 | |
| Issuance of Common Stock | 14.37 | 9.07 | 12.08 | 0.32 | 10.09 | |
| Other Financing Activities | -0.63 | -0.75 | -1.67 | -0.1 | -1.07 | |
| Financing Cash Flow | 13.04 | 8.56 | 10.23 | 0.05 | 8.81 | |
| Foreign Exchange Rate Adjustments | - | - | - | - | -0.01 | |
| Net Cash Flow | 6.87 | -4.3 | 3.14 | -7.22 | 2.51 | |
| Free Cash Flow | -5.59 | -12.27 | -6.85 | -7.11 | -6.33 | |
| Free Cash Flow Margin | - | - | -1798.42% | -1017.17% | -1094.81% | |
| Free Cash Flow Per Share | -50.97 | - | - | - | - | |
| Cash Interest Paid | 0.01 | - | 0.01 | 0.02 | 0.02 | |
| Cash Income Tax Paid | -0.71 | -0.13 | -0.85 | -0.68 | -1.16 | |
| Levered Free Cash Flow | -1 | -13.15 | -0.53 | -5.32 | -5.3 | |
| Unlevered Free Cash Flow | -0.86 | -13.04 | -0.51 | -5.28 | -5.27 | |
| Change in Working Capital | 1.72 | -3.74 | -0.05 | 0.52 | -0.62 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.